Skip navigation
Agenda

Actionable Strategies for Leveraging Real-World Data, Sharing Risk and Aligning Price with Value

October 2-3, 2019
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

DAY ONE WEDNESDAY, OCTOBER 2, 2019 PRE-CONFERENCE WORKSHOP

8:00

Workshop Registration and Continental Breakfast

8:30 PRE-CONFERENCE WORKSHOP Change Management for Value-Based Contracting Workshop

Attend this cutting-edge workshop to gain practical intelligence on biopharmaceutical value-based contracting in the U.S. If you are an embryonic entrant to VBA or a fully-fledged expert, this pragmatic workshop will provide you and your organization with a wealth of tangible insight.

Workshop Outline:

I. Moving the Organization from Volume to Value

II. The Current VBA Trends

III. The Journey Along the VBA Adoption Curve

IV. The Structures that Support VBA

V. Developing with Local and Global in Mind

Workshop Leaders:

Nick Merryfield
CEO
Verpora

Omar Ali
Visiting Lecturer, University of Portsmouth;
former Adviser, NICE

11:30

Close of Pre-Conference Workshop

There will be a 30-minute networking and refreshment break at 10:30am

11:30

Networking Luncheon for Workshop Attendees

MAIN CONFERENCE
WEDNESDAY, OCTOBER 2, 2019

Antitrust Guidelines for the Conference

The U.S. antitrust laws prohibit competitors from taking collective action that unreasonably restrains trade. No confidential or competitively sensitive information is discussed at the conference and this meeting is not intended to lead to any industry agreement on what participants can or will do with respect to contracting or pricing.

12:00

Main Conference Registration

12:30

Chairs' Welcome and Opening Remarks

Jerry Taglianetti
Director, Biosimilars Contract Strategy, U.S. Payer & Channel Access
Pfizer

Richard Demers, MS, RPh, FASHP
Chief Administrative Officer, Ambulatory Pharmacy Services
University of Pennsylvania Health System

1:00

Extracting the Value from Real World Evidence in Value-Based Care (VBC)

Alan Polnariev
Medical Science Liaison, Oncology/Urology, Gastroenterology
Ferring Pharmaceuticals

1:45

Drug Leasing —
The Next Frontier for Access to Cell and Gene Therapies?
Can We Pay for a Cure?

Omar Ali
Visiting Lecturer, University of Portsmouth;
former Adviser, NICE

2:30

Networking and Refreshment Break

3:00

PANEL DISCUSSION Patients in the Middle — Can Stakeholders Align to
Address Unmet Medical Need and Enhance Patient Outcomes?

MODERATOR:

Richard Demers, MS, RPh, FASHP
Chief Administrative Officer, Ambulatory Pharmacy Services
University of Pennsylvania Health System

PANELISTS:

Marc O’Connor
Principal/ Chief Business Officer
Curant Health

Kayse Reitmeyer
Manager, Pharmaceutical Manufacturer Relations and Rebate Administration
Highmark Inc.

Jerry Taglianetti
Director, Biosimilars Contract Strategy, U.S. Payer & Channel Access
Pfizer

3:45

Value Based Contracts — Operational Challenges and Best Practices

Robert Blank
Managing Consultant
EVERSANA

4:30

Balance Adherence and Compliance with Patient Support Services

Garineh Dovletian
Independent Life Sciences Consultant;
former Vice President, Legal and Compliance
Pernix Therapeutics

Christopher Jackson
Managing Member
The Law Office of Christopher S. Jackson LLC

5:15

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO THURSDAY, OCTOBER 3, 2019

7:30

Continental Breakfast

8:00

Chairs' Review of Day One

Jerry Taglianetti
Director, Biosimilars Contract Strategy, U.S. Payer & Channel Access
Pfizer

Richard Demers, MS, RPh, FASHP
Chief Administrative Officer, Ambulatory Pharmacy Services
University of Pennsylvania Health System

8:15

Operationalizing Outcomes-Based Contracting v.2020

Tim Reiser
Principal
HighPoint Solutions, an IQVIA Company

Kunal Akwalia
Senior Manager
HighPoint Solutions, an IQVIA Company

9:00

A Closer Look at Return of Investment (ROI) vs. Value of Investment (VOI) for Outcomes-Based Contracts

Kayse Reitmeyer
Manager, Pharmaceutical Manufacturer Relations and Rebate Administration
Highmark Inc.

9:45

CASE STUDY Lessons Learned in Co-Creating Outcomes-Based Agreements —
Case Study on Blue Cross and Blue Shield of MN and Medtronic Diabetes

Tom Arnold
Senior Director, Health Plan Solutions
Medtronic Diabetes

Mark Steffen
Chief Medical Officer
Blue Cross Blue Shield of Minnesota

10:30

Networking and Refreshment Break

11:00

Leverage Technology to Improve Data Collection, Analysis & Transparency

Marc Duey
President
ProMetrics, Inc.

11:45

PAYER SURVEY RESULTS REVEAL Insights into Payer Perspectives on Outcomes-Based Contracting

Sarah Butler Donovan
Senior Vice President, Practice Director, Client Solutions
Avalere Health

John Linnehan
Senior Vice President, Health Economics & Advanced Analytics
Avalere Health

12:30

Networking Luncheon

1:30

CASE STUDY Address the Complexities of Standardizing Innovative Contracting Methods

Jeff Dunkel
Executive Team Member, Executive Vice President of Strategy
Titan Spine

2:15

Convergence of Real-World Evidence (RWE) with Health Economics and
Outcomes Research (HEOR)

Alex Cockerham, PharmD, RPh, MSc
Global Health Economics & Value Assessment, Cardiovascular Lead
Sanofi

3:00

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE WEDNESDAY, OCTOBER 2, 2019 PRE-CONFERENCE WORKSHOP

8:00

Workshop Registration and Continental Breakfast

8:30 PRE-CONFERENCE WORKSHOP Change Management for Value-Based Contracting Workshop

Attend this cutting-edge workshop to gain practical intelligence on biopharmaceutical value-based contracting in the U.S. If you are an embryonic entrant to VBA or a fully-fledged expert, this pragmatic workshop will provide you and your organization with a wealth of tangible insight.

Workshop Outline:

I. Moving the Organization from Volume to Value

II. The Current VBA Trends

III. The Journey Along the VBA Adoption Curve

IV. The Structures that Support VBA

V. Developing with Local and Global in Mind

Workshop Leaders:

Nick Merryfield
CEO
Verpora

Omar Ali
Visiting Lecturer, University of Portsmouth;
former Adviser, NICE

11:30

Close of Pre-Conference Workshop

There will be a 30-minute networking and refreshment break at 10:30am

11:30

Networking Luncheon for Workshop Attendees

MAIN CONFERENCE
WEDNESDAY, OCTOBER 2, 2019

Antitrust Guidelines for the Conference

The U.S. antitrust laws prohibit competitors from taking collective action that unreasonably restrains trade. No confidential or competitively sensitive information is discussed at the conference and this meeting is not intended to lead to any industry agreement on what participants can or will do with respect to contracting or pricing.

12:00

Main Conference Registration

12:30

Chairs' Welcome and Opening Remarks

Jerry Taglianetti
Director, Biosimilars Contract Strategy, U.S. Payer & Channel Access
Pfizer

Richard Demers, MS, RPh, FASHP
Chief Administrative Officer, Ambulatory Pharmacy Services
University of Pennsylvania Health System

1:00

Extracting the Value from Real World Evidence in Value-Based Care (VBC)

Alan Polnariev
Medical Science Liaison, Oncology/Urology, Gastroenterology
Ferring Pharmaceuticals

1:45

Drug Leasing —
The Next Frontier for Access to Cell and Gene Therapies?
Can We Pay for a Cure?

Omar Ali
Visiting Lecturer, University of Portsmouth;
former Adviser, NICE

2:30

Networking and Refreshment Break

3:00

PANEL DISCUSSION Patients in the Middle — Can Stakeholders Align to
Address Unmet Medical Need and Enhance Patient Outcomes?

MODERATOR:

Richard Demers, MS, RPh, FASHP
Chief Administrative Officer, Ambulatory Pharmacy Services
University of Pennsylvania Health System

PANELISTS:

Marc O’Connor
Principal/ Chief Business Officer
Curant Health

Kayse Reitmeyer
Manager, Pharmaceutical Manufacturer Relations and Rebate Administration
Highmark Inc.

Jerry Taglianetti
Director, Biosimilars Contract Strategy, U.S. Payer & Channel Access
Pfizer

3:45

Value Based Contracts — Operational Challenges and Best Practices

Robert Blank
Managing Consultant
EVERSANA

4:30

Balance Adherence and Compliance with Patient Support Services

Garineh Dovletian
Independent Life Sciences Consultant;
former Vice President, Legal and Compliance
Pernix Therapeutics

Christopher Jackson
Managing Member
The Law Office of Christopher S. Jackson LLC

5:15

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO THURSDAY, OCTOBER 3, 2019

7:30

Continental Breakfast

8:00

Chairs' Review of Day One

Jerry Taglianetti
Director, Biosimilars Contract Strategy, U.S. Payer & Channel Access
Pfizer

Richard Demers, MS, RPh, FASHP
Chief Administrative Officer, Ambulatory Pharmacy Services
University of Pennsylvania Health System

8:15

Operationalizing Outcomes-Based Contracting v.2020

Tim Reiser
Principal
HighPoint Solutions, an IQVIA Company

Kunal Akwalia
Senior Manager
HighPoint Solutions, an IQVIA Company

9:00

A Closer Look at Return of Investment (ROI) vs. Value of Investment (VOI) for Outcomes-Based Contracts

Kayse Reitmeyer
Manager, Pharmaceutical Manufacturer Relations and Rebate Administration
Highmark Inc.

9:45

CASE STUDY Lessons Learned in Co-Creating Outcomes-Based Agreements —
Case Study on Blue Cross and Blue Shield of MN and Medtronic Diabetes

Tom Arnold
Senior Director, Health Plan Solutions
Medtronic Diabetes

Mark Steffen
Chief Medical Officer
Blue Cross Blue Shield of Minnesota

10:30

Networking and Refreshment Break

11:00

Leverage Technology to Improve Data Collection, Analysis & Transparency

Marc Duey
President
ProMetrics, Inc.

11:45

PAYER SURVEY RESULTS REVEAL Insights into Payer Perspectives on Outcomes-Based Contracting

Sarah Butler Donovan
Senior Vice President, Practice Director, Client Solutions
Avalere Health

John Linnehan
Senior Vice President, Health Economics & Advanced Analytics
Avalere Health

12:30

Networking Luncheon

1:30

CASE STUDY Address the Complexities of Standardizing Innovative Contracting Methods

Jeff Dunkel
Executive Team Member, Executive Vice President of Strategy
Titan Spine

2:15

Convergence of Real-World Evidence (RWE) with Health Economics and
Outcomes Research (HEOR)

Alex Cockerham, PharmD, RPh, MSc
Global Health Economics & Value Assessment, Cardiovascular Lead
Sanofi

3:00

Close of Conference